Skip to Content
Merck
CN
  • Metabolic engineering of Escherichia coli for the production of four-, five- and six-carbon lactams.

Metabolic engineering of Escherichia coli for the production of four-, five- and six-carbon lactams.

Metabolic engineering (2017-04-10)
Tong Un Chae, Yoo-Sung Ko, Kyu-Sang Hwang, Sang Yup Lee
ABSTRACT

Microbial production of chemicals and materials from renewable sources is becoming increasingly important for sustainable chemical industry. Here, we report construction of a new and efficient platform metabolic pathway for the production of four-carbon (butyrolactam), five-carbon (valerolactam) and six-carbon (caprolactam) lactams. This pathway uses ω-amino acids as precursors and comprises two steps. Activation of ω-amino acids catalyzed by the Clostridium propionicum β-alanine CoA transferase (Act) followed by spontaneous cyclization. The pathway operation was validated both in vitro and in vivo. Three metabolically engineered Escherichia coli strains were developed by introducing the newly constructed metabolic pathway followed by systems-level optimization, which resulted in the production of butyrolactam, valerolactam and caprolactam from renewable carbon source. In particular, fed-batch fermentation of the final engineered E. coli strain produced 54.14g/L of butyrolactam in a glucose minimal medium. These results demonstrate the high efficiency of the novel lactam pathway developed in this study.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
δ-Valerolactam, 98%